The symposium is being hosted by the Cedars-Sinai Regenerative Medicine Institute, led by Clive Svendsen, PhD. The institute brings basic researchers with specialist clinicians together, physician researchers and translational scientists across multiple medical specialties to convert fundamental stem cell studies to therapeutic regenerative medicine. FEATURED RESEARCH: The symposium’s morning session will feature an overview of the current state of stem cells and diabetes, including attempts to start out the first scientific trials with stem cells for the treating diabetes. Other study to be presented contains an update on regenerative medicine approaches to treating macular degeneration, a progressive deterioration of the optical eye that causes gradual lack of vision.Both calcitriol and QW slowed the progression of prostate cancer in intact TRAMP mice after 14 weeks of treatment as indicated by decreased reproductive tract and prostate weight. In addition, chronic treatment of mice with calcitriol markedly decreased tumor burden, although side effects were observed in some mice. Related StoriesCrucial change in single DNA base predisposes children to intense type of cancerSausages With Antioxidants From Berries TO AVOID CancerNew antenna-like gadget makes breast cancer medical procedures easier for surgeonsThe aftereffect of calcitriol and QW on hormone refractory prostate cancer was also investigated, using castrated TRAMP mice.